Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-γ-activated SJL/J astrocytes

Journal of Immunology

Volumn 160, Issue 9, 1998, Pages 4271-4279

  Tan, Litjen ^a   Gordon, Kenneth B ^a   Mueller, John P ^b   Matis, Louis A ^b   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b ALEXION PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; EPITOPE; GAMMA INTERFERON; H2 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN PROTEIN; PROTEOLIPID; VASCULAR CELL ADHESION MOLECULE 1;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; ASTROCYTE; DEMYELINATING DISEASE; FEMALE; GLIA CELL; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD80; ASTROCYTES; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES; INTERFERON-GAMMA, RECOMBINANT; LYMPHOCYTE ACTIVATION; MICE; MYELIN SHEATH; NERVE TISSUE PROTEINS; T-LYMPHOCYTES;

EID: 0032080658     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Brown, A. M., and D. E. McFarlin. 1981. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab. Invest. 45:278.
2. Lublin, F. D., P. H. Maurer, R. G. Berry, and D. Tippett. 1981. Delayed, relapsing experimental allergic encephalomyelitis in mice. J. Immunol. 126:819.
3. 1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant. J. Immunol. 130:191.
4. Trotter, J. L., H. B. Clark, K. G. Collins, C. L. Wegeschiede, and J. D. Scarpellini. 1987. Myelin proteolipid protein induces demyelinating disease in mice. J. Neurol. Sci. 79:173.
5. - T lymphocytes. J. Immunol. 127:1420.
6. Mokhtarian, F., D. E. McFarlin, and C. S. Raine. 1984. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature 309:356.
7. van der Veen, R. C., J. L. Trotter, H. B. Clark, and J. A. Kapp. 1989. The adoptive transfer of chronic relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein. J. Neuroimmunol. 21:183.
8. Lublin, F. D. 1985. Relapsing experimental allergic encephalomyelitis. An autoimmune model of multiple sclerosis. Springer Semin. Immunopathol. 8:197.
9. Arnason, B. G. 1983. Relevance of experimental allergic encephalomyelitis to multiple sclerosis. Neurol. Clin. 1:765.
10. Kennedy, M. K., L. J. Tan, M. C. Dal Canto, V. K. Tuohy, Z. J. Lu, J. L. Trotter, and S. D. Miller. 1990. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides. J. Immunol. 144:909.
11. Tuohy, V. K., R. A. Sobel, Z. Lu, R. A. Laursen, and M. B. Lees. 1992. Myelin proteolipid protein: minimum sequence requirements for active induction of autoimmune encephalomyelitis in SWR/J and SJL/J mice. J. Neuroimmunol. 39:67.
12. Tuohy, V. K., Z. Lu, R. A. Sobel, R. A. Laursen, and M. B. Lees. 1989. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142:1523.
13. Tuohy, V. K. 1994. Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review. Neurochem. Res. 19:935.
14. McRae, B. L., C. L. Vanderlugt, M. C. Dal Canto, and S. D. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of EAE in the SJL/J mouse. J. Exp. Med. 182:75.
15. Tan, L. J., M. K. Kennedy, and S. D. Miller. 1992. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition. J. Immunol. 148:2748.
16. Miller, S. D., B. L. McRae, C. L. Vanderlugt, K. M. Nikcevich, J. G. Pope, L. Pope, and W. J. Karpus. 1995. Evolution of the T cell repertoire during the course of experimental autoimmune encephalomyelitis. Immunol. Rev. 144:225.
17. Yu, M., J. M. Johnson, and V. K. Tuohy. 1996. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183:1777.
18. Johns, L. D., K. C. Flanders, G. E. Ranges, and S. Sriram. 1991. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. J. Immunol. 147:1792.
19. Aharoni, R., D. Teitelbaum, R. Arnon, and J. Puri. 1991. Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen-Ia complex. Nature 351:147.
20. Brocke, S., K. Gijbels, M. Allegretta, I. Ferber, C. Piercy, Blankenstein, T, R. Martin, U. Utz, N. Karin, D. Mitchell, T. Veromaa, A. Waisman, Gaur, A, P. Conlon, N. Ling, P. J. Fairchild, D. C. Wraith, A. O'Garra, C. G. Fathman, and L. Steinman. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379:343.
21. Karpus, W. J., N. W. Lukacs, B. L. McRae, R. M. Streiter, S. L. Kunkel, and S. D. Miller. 1995. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155:5003.
22. + T lymphocytes in the central nervous system. Clin. Exp. Immunol. 98:313.
23. Gehrmann, J., Y. Matsumoto, and G. W. Kreutzberg. 1995. Microglia: intrinsic immuneffector cell of the brain. Brain Res. Rev. 20:269.
24. + T cells compared. J. Immunol. 154:4309.
25. Hinrichs, D. J., K. W. Wegmann, and G. N. Dietsch. 1987. Transfer of experimental allergic encephalomyelitis to bone marrow chimeras: endothelial cells are not a restricting element. J. Exp. Med. 166:1906.
26. Hickey, W. F., and H. Kimura. 1988. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290.
27. Hayes, G. M., M. N. Woodroofe, and M. L. Cuzner. 1988. Microglia express MHC class II in normal and demyelinating human white matter. Ann. NY Acad. Sci. 540:501.
28. Matsumoto, Y., K. Ohmori, and M. Fujiwara. 1992. Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions. Immunology 76:209.
29. Williams, K. C., N. P. Dooley, E. Ulvestad, A. Waage, M. Blain, V. W. Yong, and J. P. Antel. 1995. Antigen presentation by human fetal astrocytes with the cooperative effect of microglia or the microglial-derived cytokine IL-1. J. Neurosci. 15:1869.
30. Nikcevich, K. M., S. D. Hurst, T. A. Barrett, K. B. Gordon, S. D. Miller, L. Tan, J. F. Kroepfl, and M. Gardinier. 1997. Interferon-γ activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J. Immunol. 158:614.
31. Bo, L., S. Mork, P. A. Kong, H. Nyland, C. A. Pardo, and B. D. Trapp. 1994. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J. Neuroimmunol. 51:135.
32. Eddleston, M., and L. Mucke. 1993. Molecular profile of reactive astrocytes: implications for their role in neurologic disease. Neuroscience 54:15.
33. Montgomery, D. L. 1994. Astrocytes: form, functions, and roles in disease. Vet. Pathol. 31:145.
34. Matsumoto, Y., K. Ohmori, and M. Fujiwara. 1992. Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system. J. Neuroimmunol. 37:23.
35. Elliott, E. A., R. Cofiell, J. A. Wilkins, C. S. Raine, L. A. Matis, and J. P. Mueller. 1997. Immune tolerance mediated by recombinant proteolipid protein prevents experimental autoimmune encephalomyelitis. J. Neuroimmunol. 79:1.
36. Elliott, E. A., H. I. McFarland, S. H. Nye, R. Cofiell, T. M. Wilson, J. A. Wilkins, S. P. Squinto, L. A. Matis, and J. P. Mueller. 1996. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J. Clin. Invest. 98:1602.
37. Hampson, D. R., and S. E. Poduslo. 1986. Purification of proteolipid protein and production of specific antiserum. J. Neuroimmunol. 11:117.
38. Sherman, G., and J. Folch-Pi. 1970. Rotatory dispersion and circular dichroism of brain "proteolipid" protein. J. Neurochem. 17:597.
39. Anderson, M. S., and J. Miller. 1992. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 89:2282.
40. Naujokas, M. F., M. Morin, M. S. Anderson, M. Peterson, and J. Miller. 1993. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 74:257.
41. Sant, A. J., and J. Miller. 1994. MHC class II antigen processing: biology of invariant chain. Curr. Opin. Immunol. 6:57.
42. Peterson, M., and J. Miller. 1992. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature 357:596.
43. Kropshofer, H., G. J. Hammerling, and A. B. Vogt. 1997. How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol. Today 18:77.
44. Kropshofer, H., S. O. Arndt, G. Moldenhauer, G. J. Hammerling, and A. B. Vogt. 1997. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 6:293.
45. Van Cool, S. W., P. de Vandenberghe, B. M., and J. L. Ceuppens. 1996. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model. Immunol. Rev. 153:47.
46. Grewal, I. S., H. G Foellmer, K. D. Grewal, J. Xu, F. Hardardottir, J. L. Baron, C. A. Janeway, Jr., and R. A. Flavell. 1996. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273:1864.
47. - T lymphocytes by 4-1BB ligand. J. Immunol. 158:551.
48. Barish, M. E., and S. S. Raissdana. 1990. Induction of class II major histocompatibility complex antigens on a population of astrocytes from a mouse strain (BALB/c) resistant to experimental allergic encephalomyelitis. Brain Res. 510:329.
49. Frohman, E. M., T. C. Frohman, M. L. Dustin, B. Vayuvegula, B. Choi, A. Gupta, S. van den Noort, and S. Gupta. 1989. The induction of intercellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-gamma, tumor necrosis factor alpha, lymphotoxin, and inlerleukin-1: relevance to intracerebral antigen presentation. J. Neuroimmunol. 23:117.
50. Gold, R., M. Schmied, U. Tontsch, H. P. Hartung, H. Wekerle, K. V. Toyka, and H. Lassmann. 1996. Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death. A model for T-cell apoptosis in vivo. Brain 119:651.
51. Peterson, M., and J. Miller. 1990. Invariant chain influences the immunological recognition of MHC class II molecules. Nature 345:172.
52. Jenkins, M. K., and J. G. Johnson. 1993. Molecules involved in T-cell costimulation. Curr. Opin. Imnumol. 5:361.
53. + T lymphocytes. J. Immunol. 148:1985.
54. Kuchroo, V. K., C. A. Martin, J. M. Greer, S. T. Ju, R. A. Sobel, and M. E. Dorf. 1993. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental autoimmune encephalomyelitis. J. Immunol. 151:4371.
55. Miller, S. D., C. L. Vanderlugt, D. J. Lenschow, J. G. Pope, N. J. Karandikar, M. C. Dal Canto, and J. A. Bluestone. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739.
56. Merrill, J. E., D. H. Kono, J. Clayton, D. G. Ando, D. R. Hinton, and F. M. Hofman. 1992. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA 89:574.
57. Selmaj, K. W., M. Farooq, W. T. Norton, C. S. Raine, and C. F. Brosnan. 1990. Proliferation of astrocytes in vitro in response to cytokines: a primary role for tumor necrosis factor. J. Immunol. 144:129.
58. Shrikant, P., I. Y. Chung, M. E. Ballestas, and E. N. Benveniste. 1994. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-α. interleukin-1β, and interferon-γ in astrocytes. J. Neuroimmunol. 51:209.
59. Johns, L. D., G. Babcock, D. Green, M. Freedman, S. Sriram, and R. M. Ransohoff. 1992. Transforming growth factor-beta 1 differentially regulates proliferation and MHC class-II antigen expression in forebrain and brainstem astrocyte primary cultures. Brain Res. 585:229.
60. Dietsch, G. N., and D. J. Hinrichs. 1991. Mast cell proteases liberate stable encephalitogenic fragments from intact myelin. Cell. Immunol. 135:541.
61. Falo, L. D., Jr., L. J. Colarusso, B. Benacerraf, and K. L. Rock. 1992. Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 89:8347.
62. Smith, M. E., S. H. Chow, and R. H. Rolph. 1981. Partial purification and characterization of neutral proteases in lymph nodes of rats with experimental allergic encephalomyelitis. Neurochem. Res. 6:901.
63. Fontana, A., W. Fierz, and H. Wekerle. 1984. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 307:273.
64. Mossner, R., J. Sedgwick, E. Flory, H. Korner, H. Wege, and V. ter Meulen. 1990. Astrocytes as antigen presenting cells for primary and secondary T cell responses: effect of astrocyte infection by murine hepatitis virus. Adv. Exp. Med. Biol. 276:647.